Evaluation of Lorlatinib Cerebrospinal Fluid Concentrations in Relation to Target Concentrations for Anaplastic Lymphoma Kinase (ALK) Inhibition

间变性淋巴瘤激酶 脑脊液 ROS1型 医学 药代动力学 脑膜癌病 酪氨酸激酶抑制剂 胃肠病学 内科学 碱性抑制剂 药理学 癌症 肺癌 腺癌 恶性胸腔积液
作者
Steven A Sun,Yazdi K. Pithavala,Jean‐François Martini,Joseph Chen
出处
期刊:The Journal of Clinical Pharmacology [Wiley]
卷期号:62 (9): 1170-1176 被引量:20
标识
DOI:10.1002/jcph.2056
摘要

Abstract Lorlatinib is a third‐generation, brain‐penetrant anaplastic lymphoma kinase (ALK) and c‐ros oncogene 1 (ROS1) tyrosine kinase inhibitor (TKI) with robust intracranial activity in patients with ALK‐ or ROS1‐ positive non‐small cell lung cancer (NSCLC). Data from the ongoing open‐label, single‐arm, multicenter, phase‐1/2 study of lorlatinib in patients with metastatic ALK‐ or ROS1‐ positive NSCLC were used to further investigate the potential brain penetration of lorlatinib. Patients received escalating lorlatinib doses (10–200 mg once daily or 35–100 mg twice daily) or the approved dosing (100 mg daily). Plasma was collected from all patients, and cerebrospinal fluid (CSF) was collected at baseline and during the study from 5 patients with suspected or confirmed leptomeningeal carcinomatosis or carcinomatous meningitis. For those 5 patients, lorlatinib concentrations ranged from 2.64 to 125 ng/mL in the CSF and from 12.7 to 457 ng/mL in the plasma; free plasma concentrations ranged from 4.318 to 155.385 ng/mL. The CSF/free plasma ratio was 0.77 (R 2 = 0.96 and P < .001). Using a post‐hoc population pharmacokinetic model, the average steady‐state unbound plasma concentration of lorlatinib was derived and the CSF concentration was estimated for all patients. Known minimum efficacy concentrations (C eff ) for wild‐type and mutated (L1196M and G1202R) ALK were used to derive central nervous system (CNS) C eff . Estimated CNS concentrations exceeded the derived CNS C eff values in all patients for wild‐type ALK and the ALK L1196M mutation, and in 35.8% of patients for the ALK G1202R mutation. Projected lorlatinib CNS concentrations were consistent with the high intracranial response rates reported in clinical trials and provide further evidence of the potent CNS penetration of lorlatinib.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
韦远侵完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
JHJ完成签到,获得积分10
1秒前
fqw发布了新的文献求助10
1秒前
1秒前
1秒前
小海螺完成签到,获得积分10
2秒前
蔺瑾瑜完成签到,获得积分10
2秒前
策略发布了新的文献求助10
3秒前
昭昭完成签到,获得积分10
3秒前
3秒前
hzz发布了新的文献求助10
3秒前
3秒前
3秒前
3秒前
丘比特的应助被mcl采纳,获得10
3秒前
帅气的孙悟空完成签到 ,获得积分10
3秒前
4秒前
彭于晏的应助被文艺涵瑶采纳,获得10
4秒前
卷卷发布了新的文献求助30
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
ccss发布了新的文献求助10
4秒前
wanci的应助被霁月采纳,获得10
4秒前
明天见完成签到 ,获得积分10
4秒前
4秒前
一个小角色完成签到,获得积分10
5秒前
5秒前
乐乐的应助被z23采纳,获得10
5秒前
xushanqi发布了新的文献求助10
5秒前
完美世界的应助被jht456采纳,获得10
5秒前
xingxing发布了新的文献求助10
5秒前
风和日丽发布了新的文献求助10
5秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181014
求助须知:如何正确求助?哪些是违规求助? 9571039
关于积分的说明 21816042
捐赠科研通 7777369
什么是DOI,文献DOI怎么找? 3433378
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479385